Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Natl Compr Canc Netw. 2011 Nov;9(11):1293-302.

Biomarker use in colorectal cancer therapy.

Author information

  • 1University of California, San Francisco, CA, USA. Katie.Kelley@ucsf.ed

Abstract

Biomarkers reflective of the molecular and genetic heterogeneity in colorectal cancers now guide certain aspects of clinical management and offer great potential for enrichment, stratification, and identification of novel therapeutic targets in drug development. Using case-based examples, this article reviews biomarkers that have an established role in the clinical management of colorectal cancer: mismatch repair protein testing and KRAS and BRAF mutational analysis. A selection of biomarkers undergoing validation for future clinical application is presented, and the dynamic and challenging interface between biomarkers in research and clinical practice is discussed.

PMID:
22056657
[PubMed - indexed for MEDLINE]
PMCID:
PMC3696980
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk